UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells

PloS one, 2021-03, Vol.16 (3), p.e0247701-e0247701

2021

Volltextzugriff (PDF)

TIM-family proteins inhibit HIV-1 release

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (35), p.E3699-E3707

2014

Volltextzugriff (PDF)

T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (20), p.8426-8431

2011

Volltextzugriff (PDF)

Intestinal Villous M Cells: An Antigen Entry Site in the Mucosal Epithelium

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (16), p.6110-6115

2004

Volltextzugriff (PDF)

Semaphorin 7A initiates T-cell-mediated inflammatory responses through α1β1 integrin

Nature (London), 2007-04, Vol.446 (7136), p.680-684

2007

Volltextzugriff (PDF)

334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A383-A383

2023

Volltextzugriff (PDF)

Novel Immunotherapeutic Approaches to the Treatment of Cancer: Drug Development and Clinical Application

1, 2016

Volltextzugriff (PDF)

Peyer's Patches are Required for Oral Tolerance to Proteins

Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (6), p.3310-3315

2001

Volltextzugriff (PDF)

Mesenteric lymph nodes are critical for the induction of high‐dose oral tolerance in the absence of Peyer's patches

European journal of immunology, 2002-04, Vol.32 (4), p.1109-1113

2002

Volltextzugriff (PDF)

133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A146-A146

2020

Volltextzugriff (PDF)

Control of T Helper 2 Cell Function and Allergic Airway Inflammation by PKCζ

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (28), p.9866-9871

2005

Volltextzugriff (PDF)

Characterization of Aleta-001, a CAR T Engager Designed to Optimize Responses and Prevent Relapses from CAR-19 Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.1713-1713

2021

Volltextzugriff (PDF)

Cholangiocyte expression of α2β1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia

American journal of physiology: Gastrointestinal and liver physiology, 2008-07, Vol.295 (1), p.G16-G26

2008

Volltextzugriff (PDF)

Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (17), p.9803-9808

1999

Volltextzugriff (PDF)

A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo

Blood, 2019-11, Vol.134 (Supplement_1), p.252-252

2019

Volltextzugriff (PDF)

Abstract B020: CAR-CD19 T cells secreting multi-antigen bridging proteins eliminate solid tumors

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.B020-B020

2019

Volltextzugriff (PDF)

175 CAR-T engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A187-A187

2022

Volltextzugriff (PDF)

Abstract 2569: CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2569-2569

2018

Volltextzugriff (PDF)

Activity of CAR19 T cells secreting impact fusion proteins against hematopoietic and solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15046-e15046

2018

Volltextzugriff (PDF)

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Blood, 2017-12, Vol.130, p.4457-4457

2017

Volltextzugriff (PDF)

Abstract 3768: CAR T cells specific for CD19 can be redirected to kill CD19 negative tumors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3768-3768

2017

Volltextzugriff (PDF)

CD8α–11b+ dendritic cells but not CD8α+ dendritic cells mediate cross-tolerance toward intestinal antigens

Blood, 2005-07, Vol.106 (1), p.201-206

2005

Volltextzugriff (PDF)

Abstract 2759: CAR-T engager proteins for the treatment of B cell cancers and acute myeloid leukemia

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2759-2759

2022

Volltextzugriff (PDF)

Abstract A040: Hijacking CAR19 T-cells for use in targeting diverse hematopoietic and solid tumors

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.A040-A040

2019

Volltextzugriff (PDF)

TIM-family proteins inhibit HIV-1 release

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (35), p.12584-12584

2014

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(107)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(110)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Immunology
(20)
Mice
(16)
Humans
(15)
Science & Technology
(15)
Animals
(14)
Multidisciplinary Sciences
(13)
Oncology
(13)
Pharmacology
(13)
Science & Technology - Other Topics
(13)
Female
(10)
Immunotherapy
(8)
Mice, Knockout
(8)
Biological And Medical Sciences
(7)
Biological Sciences
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Proteins
(6)
Genetic Variation
(5)
Lymphocytes
(5)
Male
(5)
Mice, Inbred Balb C
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells

TIM-family proteins inhibit HIV-1 release

T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

Intestinal Villous M Cells: An Antigen Entry Site in the Mucosal Epithelium

Semaphorin 7A initiates T-cell-mediated inflammatory responses through α1β1 integrin

334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors

Novel Immunotherapeutic Approaches to the Treatment of Cancer: Drug Development and Clinical Application

Peyer's Patches are Required for Oral Tolerance to Proteins

Mesenteric lymph nodes are critical for the induction of high‐dose oral tolerance in the absence of Peyer's patches

133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies

Control of T Helper 2 Cell Function and Allergic Airway Inflammation by PKCζ

Characterization of Aleta-001, a CAR T Engager Designed to Optimize Responses and Prevent Relapses from CAR-19 Therapy

Cholangiocyte expression of α2β1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia

Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation

A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo

Abstract B020: CAR-CD19 T cells secreting multi-antigen bridging proteins eliminate solid tumors

175 CAR-T engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma

Abstract 2569: CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types

Activity of CAR19 T cells secreting impact fusion proteins against hematopoietic and solid tumors

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Abstract 3768: CAR T cells specific for CD19 can be redirected to kill CD19 negative tumors

CD8α–11b+ dendritic cells but not CD8α+ dendritic cells mediate cross-tolerance toward intestinal antigens

Abstract 2759: CAR-T engager proteins for the treatment of B cell cancers and acute myeloid leukemia

Abstract A040: Hijacking CAR19 T-cells for use in targeting diverse hematopoietic and solid tumors

TIM-family proteins inhibit HIV-1 release

Aktive Filter

Suchergebnisse filtern